2019
DOI: 10.1208/s12249-019-1363-6
|View full text |Cite
|
Sign up to set email alerts
|

Insulin Mucoadhesive Liposomal Gel for Wound Healing: a Formulation with Sustained Release and Extended Stability Using Quality by Design Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(30 citation statements)
references
References 40 publications
2
28
0
Order By: Relevance
“…Dawoud et al (2019) explored the effect of insulin mucoadhesive liposomal gel on patients with chronic wounds in different parts of the body. 43 Patients were randomly assigned to receive treatment with insulinloaded liposomal chitosan gel (n=10) or liposomal Table 2.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…Dawoud et al (2019) explored the effect of insulin mucoadhesive liposomal gel on patients with chronic wounds in different parts of the body. 43 Patients were randomly assigned to receive treatment with insulinloaded liposomal chitosan gel (n=10) or liposomal Table 2.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…Insulin-loaded liposomes included into a chitosan hydrogel demonstrated its efficacy in chronic wounds in patients, reducing the erythema and the time of wound duration. 135 Wang et al tried the liposomes using a model of diabetic rabbit with ischemic tissue. They topically administered adenosine triphosphate liposomes in the wounds and observed a faster wound closure than the control.…”
Section: Liposomes and Other Self-assembled Structuresmentioning
confidence: 99%
“…Through Franz diffusion cells, the insulin dispersion and the optimized formulation expressed a prolonged release of 6 h and up to 24 h, respectively [84]. The healing potential of insulin-containing liposomes was evaluated by the same group, which impregnated a chitosan gel with insulin-loaded liposomes and evaluated the clinical outcomes in non-diabetic patients [85]. Liposomal insulin in aqueous dispersion was stable for 6 months at 4 • C, and its release was sustained for 24 h. The clinical trial was coordinated in 15 patients over 8 months, in which liposomal insulin showed wound closure 16 times faster than the control group, with less erythema and no lowering blood sugar.…”
Section: Liposomesmentioning
confidence: 99%